Katja Weisel, MD, of the University Medical Center Hamburg-Eppendorf, Hamburg, Germany, shares her experience of the impact of COVID-19 in the management of multiple myeloma (MM) patients in Germany. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).